Postmenopausal hormone therapy offers no protection against heart attacks

Although therapy with hormones was once thought to protect women's hearts after menopause, a UCSF-led study has found that, at least for women with heart disease, estrogen plus progestin therapy does not reduce the risk of heart attack or death.

The July 3, 2002 issue of the Journal of the American Medical Association (JAMA) contains two articles with the results of the Heart and Estrogen/Progestin Replacement Follow-up Study (HERS II).

HERS was a randomized, blinded trial to determine the effects of estrogen plus progestin (compared with placebo) in older postmenopausal women with heart disease. In 1998 HERS scientists reported that, surprisingly, risk of heart attack increased in the hormone therapy group during the first year of HERS. The risk seemed to decrease in the next several years, leading to the HERS II follow-up study to evaluate the effects of longer-duration hormone therapy.

The trend toward a reduced risk of heart attacks did not persist with additional follow-up. During almost 7 years, combining HERS and HERS II, there was no reduction in risk among women taking hormones.

"This follow-up study found no reduction in risk of heart attacks or death for women with heart disease during up to seven years of hormone therapy. Not only was there no cardiovascular benefit, there were adverse affects, including blood clots and gallbladder disease," said Deborah Grady, MD, MPH, UCSF professor of epidemiology and medicine and co-principal investigator on the studies. Grady is also director of the UCSF/Mount Zion Women's Health Clinical Research Center.

The hormone therapy caused a 2-fold increase in the risk of blood clots in the legs and lungs, with most of the increased risk in the early years of treatment, according to principal investigator Stephen Hulley, MD, MPH, professor and chair of the UCSF department of epidemiology and biostatistics. There was a nearly 50 percent increase in the risk of gallbladder disease r

Contact: Maureen McInaney
University of California - San Francisco

Page: 1 2

Related medicine news :

1. Postmenopausal breast cancer survivors at increased risk for bone fractures
2. Postmenopausal women have lower grip strength than premenopausal women
3. Postmenopausal hormone therapy associated with increased risk for developing asthma
4. Postmenopausal hormone replacement therapy linked to increased risk for certain types of rarely occurring breast cancer
5. Postmenopausal Women Reap Heart Benefits From Foods Containing Vitamin E
6. Novel Therapy Significantly Reduces Spinal Fractures In Postmenopausal WomenWith Two Years Of Therapy
7. New Drug Prevents Breast Cancer In Postmenopausal Women, UCSF Researchers Report
8. Growth hormone treatment improves symptoms of metabolic disorder in postmenopausal women
9. Mood elevating hormone may trigger depression and heart problems
10. The history and controversy behind post-menopausal hormone therapy
11. Female sex hormones play a vital role in defense against sexually transmitted diseases

Post Your Comments:
(Date:10/9/2015)... PA (PRWEB) , ... October 09, 2015 , ... "As ... of two inventors from Philadelphia, Pa. "They have to wear large diapers or pads. ... solutions." , They developed the TROUSAFE to absorb urine leaking from the tip of ...
(Date:10/9/2015)... Australia (PRWEB) , ... October 09, 2015 , ... ... in an upcoming episode of Innovations with Ed Begley Jr., airing 1st QT ... segment, Innovations will educate audiences on MMJ Phytotech Limited (MMJ) – a global ...
(Date:10/9/2015)... (PRWEB) , ... October 09, 2015 , ... Santa Rosa ... their partnership as MD Anderson prepares to go-live on the Epic platform in March ... for early 2016. Santa Rosa will execute the contract by supporting Scheduling Appointment Conversion ...
(Date:10/9/2015)... ... October 09, 2015 , ... Deadly, record-smashing rainfall has caused ... (CCCF) in Columbia, South Carolina. In response, the Foundation has established a national ... both short and long term. 100% of monies donated will go directly to ...
(Date:10/9/2015)... , ... October 09, 2015 , ... Most people assume ... with more vegetables and less meat. While noted T’ai Chi Master and integrative medicine ... and Yang” relationship between the two cuisines and that they potentially complement one another, ...
Breaking Medicine News(10 mins):
(Date:10/9/2015)... -- Eli Lilly and Company (NYSE: LLY ) today ... new jobs to its research and development presence at the ... York . --> ... a translational immuno-oncology hub and a Lilly "portal," which will ... cutting-edge drug discovery capabilities, including chemistry and lead optimization expertise. ...
(Date:10/9/2015)... , Schweiz, October 9, 2015 Der ... Dr.   Yutaka Kondo und Dr.   Junko Takita ...   2015 " geht an Dr.   Yutaka ... Der " JCA-Mauvernay Award   2015 ... Dr.   Junko Takita    ™ , das ...
(Date:10/8/2015)... HERTFORDSHIRE, England and PITTSBURGH ... MYL ), a leading global pharmaceutical company, will host ... th at 5:00 pm ET to review the ... plc (NYSE: PRGO ; TASE) through Mylan,s offer ... review a comprehensive presentation which outlines the compelling proposition ...
Breaking Medicine Technology:
Cached News: